NHS partners with drugmakers to eliminate hep C

The National Health Service (NHS), the UK’s government-run health system, has partnered with Gilead Sciences, Merck Sharp and Dohme (MSD) and AbbVie to help eliminate hepatitis C in England.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

NHS to receive £250m for new AI lab

8 August 2019 The NHS will receive a £250 million investment to develop a new National AI Lab, which will use the technology to improve patient health, the UK government has announced.

Big Pharma

UK life sciences partnership to use AI in disease detection

5 December 2018 The UK government and the life sciences industry have partnered to develop new technology using artificial intelligence to detect diseases at an early stage.

Biotechnology

NHS to save £300m in biosimilar adalimumab deals

29 November 2018 The National Health Service England is set to make record-breaking savings after negotiating deals with five manufacturers of low-cost biosimilar versions of the NHS's most expensive drug.

More on this story

Big Pharma

NHS to receive £250m for new AI lab

8 August 2019 The NHS will receive a £250 million investment to develop a new National AI Lab, which will use the technology to improve patient health, the UK government has announced.

Big Pharma

UK life sciences partnership to use AI in disease detection

5 December 2018 The UK government and the life sciences industry have partnered to develop new technology using artificial intelligence to detect diseases at an early stage.

Biotechnology

NHS to save £300m in biosimilar adalimumab deals

More on this story

Big Pharma

NHS to receive £250m for new AI lab

8 August 2019 The NHS will receive a £250 million investment to develop a new National AI Lab, which will use the technology to improve patient health, the UK government has announced.

Big Pharma

UK life sciences partnership to use AI in disease detection

5 December 2018 The UK government and the life sciences industry have partnered to develop new technology using artificial intelligence to detect diseases at an early stage.

Biotechnology

NHS to save £300m in biosimilar adalimumab deals